Ambient Air Pollution Health Impacts in High‐Income Countries, Part II: A Case Study in the United Arab Emirates Authors: Tongchuan Wei, Nathan Ellermeier, Nick Kruskamp, Amal Mubarak Madhi, Latifa Juma Al Shamsi, Basema Ahmad Saddik, Jacqueline MacDonald Gibson Published: 2026 ABSTRACT ABSTRACTAmbient air pollution poses major global public health risks, particularly in rapidly developing regions, including the Arabian Gulf. This study estimates the disease burden attributable to anthropogenic air pollution (particulate matter [PM] and ozone) in Abu Dhabi, United Arab Emirates, for 2019–2022 and compares findings to previous estimates for 2008. Burdens were calculated using updated air quality, population, and health incidence data for 2019–2022 along with concentration–response functions from recent epidemiologic evidence. Results show that Abu Dhabi's investments in air quality management have paid off in preventing air quality from deteriorating as much as would be expected given the doubling of the population between 2008 and 2022. However, epidemiologic evidence gathered during this period indicates that PM exposure has stronger negative effects on mortality risks than previously thought. As a result, estimated deaths attributable to anthropogenic ambient air pollution increased between 2008 and 2022, from 231 (90% uncertainty interval [UI]: 59–427) to 1249 (90% UI: 507–2169). Total hospital visits attributable to PM and ozone exposure also increased. These increases reflect combined effects of population growth, higher pollutant exposures, improved medical record‐keeping, and updated evidence on health risks. Urban centers, with higher pollutant concentrations and population densities, experience the highest risks, highlighting the need for targeted interventions to address air pollution hotspots. This work provides policymakers with up‐to‐date insights on the health impacts of ambient air pollution and underscores the importance of continued investments in air quality management in Abu Dhabi. Introduction Globally, ambient air pollution is a major public health concern among environmental factors, contributing to an estimated 4.2 million premature deaths annually (World Health Organization 2024). In response, many nations have established air quality management programs to mitigate associated public health risks (Willis et al. 2010). The United Arab Emirates (UAE), established in 1971, has undergone rapid economic and demographic transitions. Over the past two decades, the UAE's gross domestic product has quadrupled, while its population has grown by a factor of 2.5 (World Bank Group 2024a, 2024b). While this growth has propelled the nation's development, it has also intensified pressures on the environment (Lakhani 2023). In response, the UAE government has implemented regulatory frameworks, such as the UAE National Air Quality Agenda 2031 and extensive air quality monitoring networks through the Environment Agency–Abu Dhabi (EAD), to balance industrial growth with environmental protection (United Arab Emirates Ministry of Climate Change and Environment 2023; Environment Agency–Abu Dhabi 2023). Exposure to ambient air pollution has been associated with various adverse health outcomes. Among air pollutants, exposures to particulate matter (PM) and ground‐level ozone (O3) are particularly deleterious and have been strongly linked to respiratory, cardiovascular, and metabolic diseases, as well as increased hospitalizations and mortality (U.S. Environmental Protection Agency 2019; U.S. Environmental Protection Agency 2020). Recognizing these risks, the Emirate of Abu Dhabi (the capital and the largest of the UAE's seven emirates) initiated the first comprehensive environmental health assessment in 2007 (Willis et al. 2010). This led to the development of the UAE Environmental Burden of Disease Model in 2008, which quantified the preventable environmental burden of diseases attributable to multiple environmental risk factors (MacDonald Gibson et al. 2013). This model identified anthropogenic ambient air pollution as the leading environmental risk factor for public health, contributing to an estimated 651 premature deaths and 14,600 hospital visits in the UAE during 2008 (MacDonald Gibson et al. 2013). Since then, the UAE's public health infrastructure has expanded significantly, including the establishment of the Abu Dhabi Public Health Center (ADPHC) under the Department of Health in 2019 to enhance public health protection and inform policy (ADPHC 2023). Quantifying the burden of disease attributable to ambient air pollution is important for policymakers to understand the magnitude of the problem and design strategies to mitigate associated health risks. Accurate and up‐to‐date estimates are essential for guiding effective decision‐making and prioritizing interventions across health risk factors (Shaffer et al. 2019). Comparing recent disease burden estimates with earlier figures also provides insights into the effectiveness of previous interventions and the adequacy of current policies (Zhang et al. 2024). However, the UAE Environmental Burden of Disease Model was based on 2008 air quality, health incidence, and epidemiologic data, which may not accurately reflect present conditions and therefore limit its relevance for current policy decisions. Since the original assessment in 2008 (MacDonald Gibson et al. 2013), Abu Dhabi has undergone substantial demographic, environmental, and policy changes (World Bank Group 2024a, 2024b; Lakhani 2023; United Arab Emirates Ministry of Climate Change and Environment 2023; Environment Agency – Abu Dhabi 2023). Meanwhile, epidemiologic evidence linking ambient air pollution to adverse health endpoints has continued to evolve (see Part I of this two‐part series). Thus, an updated assessment is needed to estimate the current disease burden, evaluate how it has changed over more than a decade, and identify factors contributing to any temporal changes. To inform its future programming, the ADPHC commissioned an updated assessment of the burden of disease attributable to ambient air pollution in Abu Dhabi to reflect recent changes in air quality, population growth, and epidemiologic evidence on the health impacts of air pollution. The assessment, reported here, focuses specifically on the anthropogenic component of ambient air pollution because it is potentially modifiable through emissions controls, air quality management, and other policy interventions. Although naturally occurring pollutants, such as windblown and desert dust, contribute to population exposure and may adversely affect health, these sources are less amenable to conventional air quality management interventions and are therefore outside the primary scope of this assessment. Comparing updated estimates of the burden of disease attributable to ambient air pollution with those from 2008 is important for evaluating trends and informing ongoing and future policy decisions (World Health Organization 2024). The objectives of this study are to quantify the recent burden of disease associated with population exposure to anthropogenic ambient air pollution in Abu Dhabi (2019–2022) compare these updated estimates with those from 2008 to evaluate temporal trends and inform policy decisions, including assessing the effectiveness of air pollution control programs. Methods The original UAE Environmental Burden of Disease Model estimated the burden of disease attributable to ambient air pollution and five other environmental risk factors across all seven emirates. For this study, we updated the ambient air pollution module, focusing specifically on Abu Dhabi Emirate. The updated module incorporates data from 2019 to 2022, including local incidences of adverse health outcomes, ambient air quality, and population demographics, along with new epidemiologic parameters described in Part I of this two‐part series. The 2008 and updated estimates account for risks associated with PM2.5 (particles with an aerodynamic diameter less than 2.5 µm), PM10 (particles with an aerodynamic diameter less than 10 µm), and O3 (Saxena and Sonwani 2019). This consistency enables comparison of disease burden estimates over time. The analysis was not designed to attribute pollutant concentrations or associated health burdens to specific anthropogenic emission sources; therefore, source‐specific pollutants were outside the scope of this assessment. Overview of the Environmental Burden of Disease Model The UAE Environmental Burden of Disease Model was developed using Analytica, a decision‐support software that allows for complex modeling and probabilistic simulations (Lumina Decision Systems 2023). The model includes a module for ambient air pollution using a spatial resolution of approximately 55 km2 per grid cell (Li et al. 2010). To maintain methodological consistency with the 2008 assessment and support temporal comparisons, this spatial resolution was retained in the primary analysis in this study. The overall approach for estimating the disease burden followed World Health Organization (WHO) guidelines for assessing the environmental burden of disease at national and local levels (Prüss‐Ustün and Corvalán 2006). The attributable burden of disease for a specific air pollutant and cause‐specific health endpoint was calculated for each grid cell i as the baseline incidence of the health endpoint in that grid cell multiplied by the attributable fraction: whereΔyi is mortality or morbidity for a health endpoint attributable to air pollution exposure in grid cell i in a given year;y0,i is the expected baseline incidence of the health endpoint in grid cell i in the given year; and AFi is fraction of the observed disease incidence attributable to ambient air pollution in grid cell i. The attributable fraction represents the proportion of disease incidence in a population that can be attributed to a specific exposure (Rockhill et al. 1998). Consistent with the original UAE Environmental Burden of Disease Model and more recent studies estimating the global burden of disease attributable to risk factors, within each grid cell the updated module quantifies the attributable fraction as: where RR i is the relative risk of the specific disease of interest for the specific air pollutant at the pollutant concentration in grid cell i (assuming the pollutant exposure concentration is uniform within each grid cell). To quantify the potentially modifiable disease burden associated with anthropogenic ambient air pollution, natural background concentrations were subtracted from the measured ambient concentrations before calculating attributable fractions. This is particularly relevant in Abu Dhabi, where windblown and desert dust can contribute substantially to ambient PM concentrations (Abuelgasim and Farahat 2020). However, these natural sources are less amenable to conventional emissions‐control and air quality management interventions. Subtracting natural background concentrations allows the analysis to focus on the portion of the ambient air pollution burden that is more directly relevant to policy and potentially reducible through air quality management. Background concentrations in the Emirate of Abu Dhabi were assumed to follow uniform distributions, with ranges of 5–35 µg/m3 for PM2.5, 10–90 µg/m3 for PM10, and 0–25 ppb for O3 (Li et al. 2010). The lower bounds of these ranges were based on WHO recommendations, while the upper bounds represent typical background concentrations found in arid desert regions (Anenberg et al. 2009; Ostro et al. 2000; Ostro 2004) Data Processing for Model Inputs To estimate the disease burden attributable to ambient air pollution, the model requires four primary types of input data: health incidence, ambient air quality readings, population demographics, and epidemiologic parameters. Health Incidence Annual mortality and hospital visit data in Abu Dhabi Emirate from 2019 to 2022 were provided by the Department of Health–Abu Dhabi. The selection of cause‐specific health endpoints was based on evidence of causal relationships between air pollutant exposures (short term and long term) and specific health outcomes within a population demographic group. For example, long‐term exposure to PM2.5 is associated with mortality from all‐causes, cardiovascular diseases, and respiratory diseases (see Part I of this series). To protect patients’ confidentiality, the annual health data, reported with ICD‐10 (International Classification of Diseases, Tenth Revision) codes for each cause‐specific health endpoint, were aggregated at the medical facility level rather than by patient home address. These data were used to quantify baseline health incidence rates for each health endpoint at each medical facility. Using the geographic coordinates for each facility, baseline incidence rates were spatially interpolated into grid cells using empirical Bayesian kriging (Devine et al. 1996). This interpolation approach estimated incidence rates for each grid cell based on nearby empirical data, assuming that local residents typically seek medical assistance at nearby facilities. Air Quality Ambient air quality data from 2019 to 2022 were provided by the EAD from 20 fixed‐site air quality monitoring stations. Data were categorized into daily and annual averages for short‐term and long‐term exposure, respectively. Air quality data, were spatiotemporally interpolated into each grid cell across Abu Dhabi Emirate using a nested Bayesian maximum entropy (BME) approach to capture variation at the grid‐cell scale, consistent with the 2008 study (Akita et al. 2012; de Nazelle et al. 2010). This geostatistical approach, performed in the BMElib MATLAB toolbox, combines principles from Bayesian statistics and information theory to estimate pollutant concentrations at unobserved locations based on observed data points (Christakos 1990; Christakos et al. 2002). The interpolation covered daily average concentrations for PM10 and O3 for short‐term exposure, as well as annual average concentrations for PM2.5 and O3 for long‐term exposure. Population Spatially resolved population data were obtained from the LandScan database (Oak Ridge National Laboratory 2023). The LandScan population database has a spatial resolution of 30 × 30 arc sec (approximately 1 km2). To expedite model efficiency, these original grid cells were aggregated in groups of 64 (8 × 8), leading to a grid resolution of 240 × 240 arc sec, or approximately 55 km2. The spatially resolved population data were used as the basis for quantifying the population in each grid cell. Epidemiologic Relative Risks The relative risk represents the increase in the incidence of a cause‐specific health endpoint per unit increase in pollutant concentration (Vodonos et al. 2018). Where sufficient studies published since 2008 were available from high‐income countries, we updated the relative risk coefficients in the original UAE Environmental Burden of Disease Model as shown in Table 1 (see Part I of this series for details). Where evidence was insufficient, we relied on relative risks used in the original model (MacDonald Gibson et al. 2013). Relative risks were assumed to follow a log‐linear relationship per unit of pollutant exposure. Relative risks in Table 1 are reported per 10 µg/m3 of exposure for PM10 and PM2.5 and 10 ppb for O3, so that where RR10 is the relative risk per 10 units of pollutant exposure, and Ci is the pollutant concentration in grid cell i, after subtracting the background concentration. TABLE 1Relative risks for cause‐specific health outcomes associated with air pollution exposure.PollutantExposure durationHealth endpointsRelative risk per 10‐unit increase in exposure (95% confidence interval)OriginalUpdatedPM2.5 (µg/m3)Long‐termAll‐cause mortality (adults > 30) a 1.06 (1.02–1.11)1.13 (1.05–1.22)Cardiopulmonary mortality (adults > 30)1.09 (1.03–1.16)1.09 (1.03–1.16) b Lung cancer mortality (adults > 30)1.15 (1.04–1.27)1.15 (1.04–1.27) b PM10 (µg/m3)Short‐termAll‐cause mortality1.008 (1.006–1.01)1.008 (1.006–1.01) b Respiratory mortality (children < 5) a 1.017 (1.0034–1.03)1.017 (1.0034–1.03) b Respiratory disease hospital visits a 1.008 (1.0047–1.012)1.007 (1.003–1.011)Cardiovascular disease hospital visits a 1.003 (1.0024–1.0036)1.007 (1.005–1.009)O3 (ppb)Short‐termAll‐cause mortality1.005 (1.003–1.008)1.005 (1.003–1.008) b Cardiovascular and respiratory mortality1.006 (1.003–1.01)1.006 (1.003–1.01) b Respiratory disease hospital visits a 1.03 (1.02–1.05)1.03 (1.01–1.05)Long‐termRespiratory mortality (adults > 30)1.04 (1.02–1.06)0.97 (0.87–1.08) aMain health endpoint considered in estimating total burden of disease. bNo change in relative risks between original and updated versions due to lack of sufficient studies since 2008 to support meta‐analysis. Relative risks for cause‐specific health outcomes associated with air pollution exposure. aMain health endpoint considered in estimating total burden of disease. bNo change in relative risks between original and updated versions due to lack of sufficient studies since 2008 to support meta‐analysis. Estimation and Comparison of Disease Burdens The model estimated anthropogenic disease burden attributable to each pollutant, by health endpoint and year, at both the grid‐cell scale and aggregated to the Emirate. The estimates were expressed as mean values of attributable deaths or hospital visits, with associated uncertainties (90% uncertainty interval [UI]) derived from Monte Carlo simulation with 1000 iterations (Metropolis and Ulam 1949). Disease burdens from 2019 to 2022, estimated using both the original and updated concentration–response coefficients, were compared to 2008 estimates to identify temporal trends. To avoid double counting in estimating the total disease burden attributable to anthropogenic ambient air pollution, the original UAE burden of disease study selected nonoverlapping outcomes in adding up effects across pollutants. As the best estimate of the total number of deaths attributable to air pollution, the original study summed premature mortality in adults over age 30 years associated with long‐term exposure to PM2.5 and respiratory deaths in children under age 5 attributable to short‐term PM10 exposure (MacDonald Gibson et al. 2013). The total number of preventable hospital visits was estimated in two ways: as the sum of cardiovascular and respiratory disease visits attributable to short‐term PM10 exposure (best estimate) and as this sum plus respiratory visits attributable to short‐term O3 exposure (conservative estimate). The latter estimate reflects a potential upper bound on synergistic effects from combined exposure to PM and O3 (Xu et al. 2024; He et al. 2024). Consistent with the previous study, we also report these as the main outcomes. We provide estimates of other health outcomes attributable to these pollutants for information, with the caveat that outcomes are not additive. Spatial‐Resolution Sensitivity Analysis To evaluate the sensitivity of the estimated disease burden to the selected spatial resolution, the analysis was additionally conducted using a finer grid‐cell resolution of approximately 1 km2. The same modeling framework, updated epidemiologic concentration–response coefficients, and underlying health incidence, air quality, and population datasets were applied at both the 1 and 55 km2 resolutions. Spatially varying inputs were assigned or interpolated to the corresponding grid cells at each resolution, and grid‐level estimates of attributable anthropogenic disease burden were aggregated to the Emirate level. The Emirate‐wide disease burden estimates obtained at the 1 km2 resolution were compared with those at the 55 km2 resolution to assess the impact of spatial resolution on the resulting estimates. Results To inform policy analyses related to environmental impacts on public health in the UAE, we updated the original UAE Environmental Burden of Disease Model to quantify the disease burden attributable to anthropogenic ambient air pollution in Abu Dhabi. The updates included recent air quality data, new spatially resolved data on baseline incidences of illnesses and mortality, and, where available, new epidemiologic data relevant to quantifying air quality impacts on public health in high‐income countries. Estimated Burden of Disease Attributable to Anthropogenic Ambient Air Pollution: Primary Health Outcomes Between 2019 and 2022, the disease burden attributable to anthropogenic ambient air pollution in Abu Dhabi increased. The total number of premature deaths attributable to ambient air pollution rose from 557 (90% UI: 150–1163) in 2019 to 1249 (90% UI: 507–2169) in 2022, a 2.2‐fold increase (Table 2). Hospital visits attributable to PM increased from approximately 107,000 in 2019 to 192,000 in 2022, representing a nearly two‐fold increase. The total number of hospital visits attributable to short‐term O3 exposure rose from approximately 179,000 in 2019 to 215,000 in 2022, a 20% increase. Hospital visits attributable to O3 exposure were lower in 2020 and 2021, likely reflecting improved air quality as traffic decreased dramatically during the COVID‐19 pandemic (Venter et al. 2020). Across 2019–2022, annual hospital visits attributable to PM were 11%–41% lower than those attributable to O3, underscoring that although PM is the major focus for estimated mortality attributable to long‐term exposure to ambient air pollution, O3 is an important contributor to adverse health effects from short‐term ambient air pollution exposure. TABLE 2Total disease burden attributable to anthropogenic ambient air pollution in the Emirate of Abu Dhabi from 2019 to 2022.Health endpointCalendar year2019202020212022 Attributable mortality a All‐cause mortality among adults > 30 (PM2.5, long term) 556 (150–1162) 744 (172–1652) 1,002 (276–2052) 1,247 (505–2166) Respiratory mortality in children < 5 (PM10, short term) 0.8 (0.2–1.5) 1.1 (0.3–2.2) 0.5 (0.1–1.0) 1.9 (0.6–3.5) Total mortality (best estimate) 557 (150–1,163) 745 (173–1654) 1,003 (276–2052) 1,249 (507–2169) Attributable hospital visits a Respiratory disease hospital visits (PM10, short term) 95,642 (33,590–173,408) 86,375 (32,107–157,956) 101,588 (39,919–179,041) 172,600 (73,276–303,247) Cardiovascular disease hospital visits (PM10, short term) 11,018 (4812–18,941) 12,234 (5354–20,820) 16,185 (7848–26,752) 19,718 (10,535–31,852) Respiratory disease hospital visits (O3, short term) 179,458 (67,423–322,893) 144,842 (55,385–268,772) 156,029 (57,933–284,513) 215,467 (84,054–389,022) Total hospital visits attributable to PM (best estimate) 106,660 (38,913–190,031) 98,609 (38,894–176,048) 117,773 (49,066–202,755) 192,319 (87,320–331,181) Total hospital visits including PM and O3 (conservative estimate) 286,118 (146,695–435,625) 243,451 (127,717–377,509) 273,803 (144,539–419,500) 407,786 (229,246–610,796) aThe numbers are reported as mean estimates, with the 90% uncertainty interval provided in parentheses. Total disease burden attributable to anthropogenic ambient air pollution in the Emirate of Abu Dhabi from 2019 to 2022. 556 (150–1162) 744 (172–1652) 1,002 (276–2052) 1,247 (505–2166) 0.8 (0.2–1.5) 1.1 (0.3–2.2) 0.5 (0.1–1.0) 1.9 (0.6–3.5) 557 (150–1,163) 745 (173–1654) 1,003 (276–2052) 1,249 (507–2169) 95,642 (33,590–173,408) 86,375 (32,107–157,956) 101,588 (39,919–179,041) 172,600 (73,276–303,247) 11,018 (4812–18,941) 12,234 (5354–20,820) 16,185 (7848–26,752) 19,718 (10,535–31,852) 179,458 (67,423–322,893) 144,842 (55,385–268,772) 156,029 (57,933–284,513) 215,467 (84,054–389,022) 106,660 (38,913–190,031) 98,609 (38,894–176,048) 117,773 (49,066–202,755) 192,319 (87,320–331,181) 286,118 (146,695–435,625) 243,451 (127,717–377,509) 273,803 (144,539–419,500) 407,786 (229,246–610,796) aThe numbers are reported as mean estimates, with the 90% uncertainty interval provided in parentheses. Comparison to 2008 Estimates Mortality attributable to anthropogenic air pollution in Abu Dhabi was higher in 2019–2022 compared with 2008 estimates (Figure 1). In 2008, ambient air pollution exposure was associated with an estimated 231 annual deaths (90% UI: 59–427). By 2019, the estimated disease burden had more than doubled to 557 deaths (90% UI: 150–1163), and by 2022, it had more than quintupled to 1249 deaths (90% UI: 507–2169). Comparison of estimated annual disease burdens attributable to anthropogenic ambient PM and O3 exposure in Abu Dhabi: (a) mortality (deaths); (b) morbidity (hospital visits); (c) mortality rate (deaths per 100,000 people); and (d) morbidity rate (hospital visits per 100,000 people) for 2019–2022 versus 2008. Estimates for 2019–2022 are shown using updated epidemiologic concentration–response coefficients at 1 and 55 km2 spatial resolutions and the concentration–response coefficients from the 2008 study (labeled “original”) at 55 km2 resolution. The 2008 estimates were based on the original coefficients and 55 km2 resolution. Error bars represent 90% uncertainty intervals on the mean. As is the case for the increase in disease burden attributable to anthropogenic air pollution occurring during 2019–2022, the change compared to 2008 reflects population growth and not only deteriorating air quality. However, it also reflects updated epidemiologic information about health effects associated with ambient air pollution reported in Part I of this series. For example, in the 2008 study, the relative risk of all‐cause mortality was assumed to equal 1.06 per 10 µg/m3 increase in long‐term exposure to ambient PM2.5 based on a study conducted in the United States in 2002 (Pope III et al. 2002). In contrast, our updated meta‐analysis based on studies from high‐income countries across the world published since 2008 estimated a higher relative risk of 1.13 per 10 µg/m3 of exposure. To illustrate the effects of changes in relative risks as compared to changes in air quality and population, Figure 1 also shows estimates using the same relative risks as in the 2008 study. As shown, mortality attributable to air pollution has increased substantially since 2008 even when using the same relative risks as in the original study. To assess the impact of tspatial resolution on disease burden estimates, Figure 1 also presents results from the finer‐resolution analysis. At 1 km2 resolution, the mortality attributable to anthropogenic PM and O3 increased from 2008 to 2019–2022, consistent with the temporal trends observed at the original 55 km2 resolution. This indicates that the overall temporal trends are not materially affected by spatial resolution. Compared with the estimates obtained using the updated concentration–response coefficients at the 55 km2 resolution, the corresponding 1 km2 estimates are approximately 30% lower on average. However, the 90% uncertainty intervals overlap, indicating that the differences between the two spatial resolutions are small relative to the uncertainty in the mortality estimates. Thus, increasing the spatial resolution from 55 to 1 km2 does not materially affect the conclusions regarding temporal trends in the Emirate‐wide burden of disease estimates. To maintain methodological consistency with the 2008 assessment and facilitate temporal comparisons, subsequent results are presented at the 55 km2 grid‐cell resolution. Similar to the mortality trend, there is an upward increasing trend in annual hospital visits attributable to anthropogenic PM and O3. In 2008, the total number of hospital visits was approximately 7700 (best estimate) (MacDonald Gibson et al. 2013). The updated analysis shows that total hospital visits attributable to ambient air pollution have increased, reaching between 100,000 and 200,000 annually in 2019–2022 (best estimate), more than an order of magnitude higher than in 2008. However, the increasing trends in population‐adjusted mortality or morbidity rates over 2019–2022 period relative to 2008 are less pronounced than the corresponding trends in total disease burden estimates. Between 2008 and 2022, the population of Abu Dhabi more than doubled, increasing from 1.49 to 3.17 million (Table 3). Over this period, the total number of attributable annual deaths (using the updated epidemiologic relative risks) showed a substantial increase for both PM and O3 (Figure 1a). In contrast, the mortality rate per 100,000 people increased by a notably smaller margin of 154% for PM and 66% for O3 (Figure 1c). Similarly, while the total number of attributable hospital visits increased by a factor of 25–38 (Figure 1b), the morbidity rate per 100,000 people rose by a smaller factor of 12–18 (Figure 1d). This divergence indicates that a substantial portion of the increased disease burden is driven by growth in the exposed population. TABLE 3Abu Dhabi Emirate population and air quality in 2008 and between 2019 and 2022.VariablesCalendar year20082019202020212022Population (million)1.493.083.133.143.17Annual average ambient air concentrationPollutantUnitsPM10 µg/m3 107106103115137PM2.5 µg/m3 37.533.029.734.841.5O3 ppb29.143.039.840.140.4 Abu Dhabi Emirate population and air quality in 2008 and between 2019 and 2022. While population growth accounts for a large share of the increased disease burden, deterioration in ambient air quality also remains an important contributing factor. Compared with 2008, annual‐average concentrations during the 2019–2022 period increased by 7%–48%, depending on pollutant, with the exception of temporary reductions in PM during the COVID‐19 pandemic years (Table 3). Because the relationship between air quality and health is supra‐linear (Wagner et al. 2023), each additional increment of air pollution exposure has an increasingly negative effect on health. The trend in O3 concentrations (Table 3) highlights the inherent complexity of managing secondary pollutants (Seinfeld and Pandis 2016). Unlike primary PM, ground‐level O3 is formed through non‐linear photochemical reactions involving nitrogen oxides (NOx) and volatile organic compounds (VOCs) as precursors. Regulatory controls on specific precursor emissions do not always produce immediate, proportional reductions in O3 concentrations and can, in some cases, lead to temporary increases, depending on the local atmospheric regime (Sillman 1999). Mischaracterizing these regimes (e.g., NOx‐limited vs. VOC‐limited regions) can result in counterproductive policies that fail to mitigate, or even exacerbate, the O3 burden. Our estimated mortality rates are generally consistent with global benchmarks presented in the State of Global Air 2025 report (Health Effects Institute 2025). For 2022, we estimated that the mortality rate attributable to PM2.5 in Abu Dhabi ranged from 16 to 68 deaths per 100,000 people (90% UI), which is slightly lower than the regional age‐standardized rate of 102 deaths per 100,000 people reported for the Middle East. This difference is largely attributable to differences in scope: the regional estimate in the report includes both natural and anthropogenic sources, whereas our analysis focuses specifically on anthropogenic contributions. For O3, our estimated mortality rate of 3 deaths per 100,000 people (90% UI: 1–5) is comparable to the range (3–6 deaths per 100,000 people) reported for the region. This consistency with established international assessments supports the validity of our findings, indicating that our disease burden estimates align with independent global evaluations. Overall, the substantial increases in both mortality and morbidity attributable to PM and O3 from 2008 to 2022 highlight growing public health concerns attributable to anthropogenic ambient air pollution in Abu Dhabi Emirate. The rising numbers of attributable deaths and hospital visits reflect increasing public health challenges faced by a rapidly developing region. Spatial Variability in Disease Burden Estimates Attributable to Air Pollution Health risks from anthropogenic air pollution exposure exhibit considerable spatial variability across Abu Dhabi (Figure 2). Key urban centers, such as Abu Dhabi city, are densely populated and therefore bear a larger attributable disease burden due to the higher population density and higher levels of human activity (e.g., traffic) that contribute to ambient air pollution. In 2022, annual‐average PM2.5 concentrations varied from 35 to 48 µg/m3, a 37% difference, depending on spatial location (Figure 2b). All these concentration levels exceed the WHO heath‐based guideline for annual‐average ambient PM2.5 concentrations, which is set at 5 µg/m3 (World Health Organization 2024). While WHO guidelines provide a valuable global benchmark, national and regional authorities, such as EAD, recommend developing and adopting national air quality standards tailored to local environmental and contextual conditions, which may offer a more practical and effective approach (United Arab Emirates Ministry of Climate Change and Environment 2023). The PM2.5 hotspots are typically located around industrial zones and urban areas with heavy traffic. Spatial variability in: (a) population; (b) annual average ambient PM2.5 concentration; and (c) baseline incidence rates for all‐cause mortality in adults over age 30 in the Emirate of Abu Dhabi Emirate in 2022. Note: Data are displayed at a spatial resolution of 55 km2 grid cells. Baseline incidence rates of all‐cause mortality in adults over 30 years in 2022 ranged from 61 to 266 per 100,000 people, a 4.4‐fold difference across grid cells, highlighting the spatial variability in population susceptibility to air pollution exposure (Figure 2c). Some areas experienced higher mortality rates potentially linked to higher PM2.5 exposure or other contributing factors. Variations in population density, pollution exposure, and population vulnerability drive the spatial distribution of disease burden attributable to anthropogenic ambient air pollution (Figure 3). The attributable fraction of all‐cause mortality in adults across the emirate varies from 14.5% to 27.6% across grid cells. The areas with the highest attributable fraction are clustered around Abu Dhabi city and its surrounding areas. This is consistent with the higher PM2.5 concentrations identified in Figure 2b, particularly in densely populated urban and industrial areas. In contrast, more rural and less populated areas, such as those in the eastern part of the emirate, have lower attributable fractions, reflecting lower PM2.5 exposure and consequently reduced health impacts in these regions. Similar to the attributable fraction, the highest attributable mortality rates are concentrated in and around Abu Dhabi city (Figure 3b). The areas of Abu Dhabi city where the mortality rate is approximately 70 deaths per 100,000 people correspond to the areas of highest PM2.5 concentration, indicating a correlation between air pollution levels and mortality outcomes. Although Al Ain has a higher population density, it shows lower attributable mortality rates, consistent with its lower exposure to PM2.5. Thus, the spatial distribution indicates that urbanized areas bear the highest mortality burden due to air pollution, particularly for Abu Dhabi city. The clear association between high population density, elevated ambient air quality, and increased mortality risk highlights the continued and urgent need for targeted interventions in these high‐risk areas. Spatial variability in: (a) the attributable fraction of all‐cause mortality; and (b) estimated all‐cause mortality (deaths/100,000 people) in adults over age 30 due to long‐term exposure to anthropogenic PM2.5 in the Emirate of Abu Dhabi in 2022. Note: Data are displayed at a spatial resolution of 55 km2 grid cells. Cause‐Specific Attributable Disease Burden To provide additional insights into air quality–related health effects, we also estimated the burden of disease for additional combinations of pollutant type and health outcomes not considered in our main estimates of the total disease burden (to avoid double counting). These results (Table 4) also show that premature deaths attributable to anthropogenic PM in Abu Dhabi increased from 2008 to 2022 for all health outcomes except for cardiopulmonary mortality. Cardiopulmonary mortality attributable to air pollution declined from 63 in 2008 to only 3 in 2022, with a relatively similar attributable fraction, reflecting likely advances in medical interventions and treatments. The fraction of deaths attributable to anthropogenic O3 increased between 2008 and 2019 (except for respiratory mortality) but has remained relatively stable since then, reflecting stabilized O3 concentrations in ambient air. As noted above, the estimates in Table 4 should not be combined with those in Table 2 due to the risk of double counting. TABLE 4Fraction and number of specific health outcomes attributable to anthropogenic ambient air pollution in Abu Dhabi in 2008 and between 2019 and 2022.Air pollutantExposure typeHealth endpointAttributable fraction (90% uncertainty interval) for each yearAttributable deaths (90% uncertainty interval) for each year2008201920202021202220082019202020212022PM2.5 Long‐termCardiopulmonary mortality (adults > 30) 14.2% (5.3%–26.5%) 11.1% (3.3%–22.6%) 9.1% (2.2%–20.3%) 12.1% (3.7%–24.0%) 16.0% (7.0%–27.6%) 63 (18–123) 2.7 (0.6–5.8) 1.5 (0.3–3.4) 1.8 (0.4–3.6) 3.3 (1.2–5.9) Lung cancer mortality (adults > 30) 19.8% (8.0%–37.0%) 16.2% (4.7%–33.3%) 13.4% (3.1%–29.9%) 17.7% (5.3%–35.3%) 22.3% (9.0%–38.5%) 8 (3–19) 16 (4–35) 16 (3–35) 26 (6–54) 33 (12–58) PM10 Short‐termAll‐cause mortality 4.5% (2.4%–7.4%) 4.5% (2.4%–7.2%) 4.3% (2.2%–7.0%) 5.1% (2.8%–8.0%) 6.6% (4.3%–9.4%) 150 (47–243) 243 (110–419) 338 (152–563) 395 (191–639) 489 (263–776) O3 Short‐termAll‐cause mortality 0.9% (0.3%–1.6%) 1.6% (0.8%–2.5%) 1.4% (0.7%–2.3%) 1.4% (0.7%–2.3%) 1.4% (0.7%–2.3%) 27 (7–46) 70 (31–116) 88 (39–151) 94 (40–159) 96 (44–160) Cardiovascular and respiratory mortality 1.1% (0.4%–2.0%) 1.9% (1.0%–3.2%) 1.7% (0.8%–2.9%) 1.8% (0.8%–2.9%) 1.8% (0.9%–2.9%) 10 (2–18) 33 (15–57) 37 (16–63) 43 (18–75) 45 (20–76) Long‐termRespiratory mortality (adults > 30) 13.9% (7.3%–21.2%) 4.4% (0.0%–26.1%) 4.0% (0.0%–24.0%) 4.2% (0.0%–25.1%) 4.2% (0.0%–24.9%) 8 (4–12) 15 (0–87) 17 (0–102) 34 (0–201) 26 (0–154) Fraction and number of specific health outcomes attributable to anthropogenic ambient air pollution in Abu Dhabi in 2008 and between 2019 and 2022. 14.2% (5.3%–26.5%) 11.1% (3.3%–22.6%) 9.1% (2.2%–20.3%) 12.1% (3.7%–24.0%) 16.0% (7.0%–27.6%) 63 (18–123) 2.7 (0.6–5.8) 1.5 (0.3–3.4) 1.8 (0.4–3.6) 3.3 (1.2–5.9) 19.8% (8.0%–37.0%) 16.2% (4.7%–33.3%) 13.4% (3.1%–29.9%) 17.7% (5.3%–35.3%) 22.3% (9.0%–38.5%) 8 (3–19) 16 (4–35) 16 (3–35) 26 (6–54) 33 (12–58) 4.5% (2.4%–7.4%) 4.5% (2.4%–7.2%) 4.3% (2.2%–7.0%) 5.1% (2.8%–8.0%) 6.6% (4.3%–9.4%) 150 (47–243) 243 (110–419) 338 (152–563) 395 (191–639) 489 (263–776) 0.9% (0.3%–1.6%) 1.6% (0.8%–2.5%) 1.4% (0.7%–2.3%) 1.4% (0.7%–2.3%) 1.4% (0.7%–2.3%) 27 (7–46) 70 (31–116) 88 (39–151) 94 (40–159) 96 (44–160) 1.1% (0.4%–2.0%) 1.9% (1.0%–3.2%) 1.7% (0.8%–2.9%) 1.8% (0.8%–2.9%) 1.8% (0.9%–2.9%) 10 (2–18) 33 (15–57) 37 (16–63) 43 (18–75) 45 (20–76) 13.9% (7.3%–21.2%) 4.4% (0.0%–26.1%) 4.0% (0.0%–24.0%) 4.2% (0.0%–25.1%) 4.2% (0.0%–24.9%) 8 (4–12) 15 (0–87) 17 (0–102) 34 (0–201) 26 (0–154) Limitations The increase in disease burden estimates, particularly for hospital visits, may partially reflect changes in medical recordkeeping system since 2008, including the addition of approximately 100 medical facilities reporting in Abu Dhabi over this period. Although these estimates indicate a growing public health burden attributable to anthropogenic ambient air pollution, some of the increase is likely due to more comprehensive data collection and greater accessibility to health services in recent years. These advances in medical recordkeeping strengthen public health monitoring, but also introduce challenges when comparing disease burdens across different time periods. The disease burden estimates are based on health records linked to medical facility locations rather than patient home addresses, which were unavailable due to privacy restrictions and data sharing policies. Baseline health incidence rates were therefore spatially interpolated from facility‐level data across the Emirate. Consequently, although the sensitivity analysis was conducted at an approximately 1 km2 spatial resolution, the finer grid better preserved modeled spatial variability in air pollution exposure and population but could not recover spatial variability that was not captured by the underlying facility‐level health data. Access to patient home address data would allow for a more precise quantification of spatially resolved health incidence rates, offering clearer insights into the geographic distribution of health impacts. Exploring opportunities to securely access patient home addresses with medical records, while complying with privacy protection policies, would refine the spatial analysis and improve the disease burden estimates. The relative risks used in this work are based on epidemiological evidence drawn from a systematic literature review (Part I of this series) based on evidence from high‐income countries. These estimates may not completely reflect the unique demographic, environmental, and health characteristics of the UAE. To improve the robustness and relevance of future disease burden estimates, large‐scale environmental epidemiological studies tailored to the UAE's population and environmental conditions would be needed. Supporting such research will facilitate the development of evidence‐based air quality regulations and improve national public health risk assessments. In addition, this study estimates disease burden based on population exposure to ambient PM and O3 and does not attribute the estimated burden to specific anthropogenic emission sources. Ambient concentrations of these pollutants reflect contributions from multiple sources as well as atmospheric transport, transformation, and secondary formation. Thus, the results cannot be used to determine the proportion of disease burden attributable to individual sources, such as transportation, industrial activities, power generation, and oil and gas operations. Future work integrating emissions inventories with atmospheric chemical transport modeling and source‐apportionment analyses could quantify source contributions to ambient concentrations and their associated health burdens. Such analyses would complement the present exposure‐based disease burden assessment and provide additional information for prioritizing source‐specific emission‐control strategies. Conclusions This study extends the original UAE Environmental Burden of Disease assessment by incorporating recent Abu Dhabi‐specific air quality, demographic, and health incidence data; updating concentration–response relationships using more recent epidemiologic evidence, particularly from high‐income populations; quantifying disease burden over multiple recent years (2019–2022); and evaluating its spatial variability across the Emirate. Importantly, maintaining the methodological continuity with the original 2008 assessment provides a consistent basis for evaluating how estimated disease burdens have changed over more than a decade and identifying factors contributing to these changes, thereby informing future air quality management and public health decision‐making. The temporal comparisons highlight the escalating burden of disease attributable to anthropogenic ambient air pollution in the Abu Dhabi Emirate, reflecting the combined influences of rapid population growth, changes in air quality, improvements in medical recordkeeping systems, and the incorporation of updated, more robust epidemiologic evidence. The number of attributable deaths and hospital visits linked to anthropogenic ambient PM and O3 exposure increased between 2008 and 2019 and has continued to rise since then. While a large portion of this increase is explained by rapid growth in the exposed population and improved health data, trends in ambient air quality, particularly for PM, remain a critical contributing factor, reflecting the environmental challenges faced by regions undergoing rapid economic and industrial expansion. The persistence of air pollution challenges, despite substantial government investments in monitoring and source control, underscores the long‐term nature of air quality management. The complexity of atmospheric chemistry in the region (e.g., for O3) means that improvements in air quality often lag behind the implementation of control measures. The spatial variability in disease burdens across the emirate indicates urban centers, such as Abu Dhabi city, experience the highest rates of mortality and morbidity due to their higher pollutant concentrations and population densities. This spatial disparity emphasizes the need for continued and targeted interventions to address air pollution hotspots and, thus, reduce health disparities. The spatially resolved regional‐scale analysis, as presented here, provides policymakers with actionable evidence to identify high‐risk areas and prioritize mitigation efforts where they are most needed. The updated disease burden estimates offer an improved understanding of the health impacts of ambient air pollution in Abu Dhabi. These findings quantify the potential public health burden associated with anthropogenic ambient PM and O3 exposure and can support broader air quality management and health‐protection strategies. Rather than signaling that past air quality control programs have been ineffective, these findings validate the urgent need to sustain and expand proactive policy measures. Indeed, without the measures already in place, the burden of disease attributable to ambient air pollution would be much higher, considering that the population has more than doubled since 2008, while ambient pollution levels have increased by a much smaller amount (28%, 11%, and 39% for PM10, PM2.5, and O3, respectively). Continuing efforts to invest in cleaner technologies, further strengthen current air quality standards, and increase public awareness will limit the adverse environmental and human health effects of continued population and industrial growth. A coordinated strategy that integrates public health considerations into environmental policies and urban planning across the UAE will ensure a sustainable future growth trajectory. This study highlights the importance of continuously updating and refining the burden of disease model to reflect current environmental conditions and to offer policymakers the most recent, accurate, and actionable information. It also establishes a foundation for future studies to monitor trends and evaluate the effectiveness of interventions aimed at improving air quality and protecting public health. Funding The research work presented herein was funded by the Abu Dhabi Public Health Center, United Arab Emirates, under the Indoor Air Quality Phase II and III Action Plan. Conflicts of Interest The authors declare no conflicts of interest. Acknowledgments We extend our sincere thanks to the Environment Agency—Abu Dhabi for providing the ambient air quality data. We are also grateful to Dr. Jens Thomsen for his role in coordinating the project and providing health records data during the early phase of the project. In addition, we appreciate Dr. Marc Serre's guidance on using the BMElib MATLAB toolbox for the spatial interpolation of air quality data. The contents of this paper do not necessarily reflect the official views or policies of either the Abu Dhabi Public Health Center or the Environment Agency—Abu Dhabi. References